A Global Consulting Company
yyissa@pharmaligent.com

About Us

Home » About Us

How we got started

Yusef Yacouba-Issa is the founder of PHARMALIGENT LLC which provides global Quality Assurance, Quality Control and Pharmaceutical consulting to develop programs and compliance processes that are fit for purpose. Dr. Yacouba-Issa has served as Quality representative during FDA, EMEA, TGA, PMDA, Health Canada, Genzyme and African Health authorities’ inspections and is considered a subject matter expert in GxP compliance activities for biologics, cell therapies, gene therapies and small molecules. Our expertise includes solid, liquid, topical, sterile, and other dosage forms, medical devices, and APIs in the US and abroad.

Why Choose Us?

Results Driven

We provide independent consulting that is proven, results-driven, and with excellent communication.

Knowledgeable

With the best minds in the pharmaceutical industry, we guarantee you will get outstanding results.

Experienced

We have over 15 years experience providing expert quality and compliance advice to FDA-regulated organizations.

Targeted

With our expert staff we analyze and prepare a custom plan with specific targets for your organization.

Our Expertise

 

  • Drug Development, Manufacturing, QA, QC, Quality Systems -Commercial drugs

  • Remediation of FDA commitments to 483s/Warning Letters

  • Site Validation Master Plan/ Cleaning Validation and Critical Utilities

  • Product Formulation, API Manufacturing

  • International regulatory audit response, Labelling & Packaging Finished Product

  • Change Controls / CAPA s /Deviations

  • IQ, OQ, PQ Validation Excutions

  • Product quality and trending analysis

  • QA/QC Laboratory operations support

  • Impact analysis and Risk Assessments

  • Batch record and SOP reviews

  • Root Cause Analysis; FMEA

  • Tech. Transfer from R&D to commercial

  • GMP Training; policies and procedures development and review; PAT/QbD

  • Medical device: GXP quality systems reviews and CAPA investigations / remediation; QMS audits; risk assessments

  • CSV Part 11 quality assurance audits

  • Supplier qualification programs

  • Annual product review preparation and evaluation and SOP reviews

  • Record retention cGMP requirements

  • Data integrity audits / application integrity policy procedure development

  • Bioavailability / Bioequivalence studies

  • Quality assurance support for critical utilities, equipment and facilities

  • Deviation investigations

  • Customer complaint remediation